Primary Packaging Glass

Primary Packaging Glass
Product Description

Our moulded glass product lines cover all the pharmaceutically relevant glass categories using borosilicate glass of type I and soda-silica glass of types II and III. In addition to our products made of amber and clear glass, we also produce coloured pharma glass and opaque opal glass. Our product range includes all the common mouth shapes in capacities from 2 to 4,000 ml and we can print or acid-etch our glass products on request. Besides our standard products we also develop custom glass packaging.
We also have glass syringes in our product portfolio.

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator
Specifications
  • Supplied from
    Belgium; China; France; Germany; India; Mexico; Poland; Singapore; United States

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator

More Products from Gerresheimer AG (4)

  • Primary Packaging Plastics

    Product Primary Packaging Plastics

    We offer a widely varied spectrum of packaging solutions within solid, liquid and ophthalmic applications. Our leading brands are Duma®, Dudek™ and Triveni for solid dosage, edp-branded PET bottles for liquid dosage. Our standard range includes a wide choice of different types of containers and closures, ...
  • Micro infusion pumps

    Product Micro infusion pumps

    Sensile Medical is a pioneer in liquid drug delivery pump devices with a typical total volume of 3 – 20 ml. The subcutaneous medication at home combined with digital solutions is attractive for all stakeholders of the health care System.
  • Customized solutions drug delivery systems

    Product Customized solutions drug delivery systems

    Customized drug delivery systems – from the concept development through industrialization to assembly, and pharmaceutical filling. We cover the entire spectrum of delivery types: inhaler, syringes, pen systems, auto injectors and infusion sets as well as lab disposables and point of care tests.
  • Primary packaging for biologics

    Product Primary packaging for biologics

    Primary packaging for sensitive, biotechnologically manufactured active agents. Highest quality standards with regard to active agent-packaging interaction, increased user-friendliness and application safety for patients and user.

Gerresheimer AG resources (6)

  • News Gerresheimer at CPHI Worldwide: global presence for innovative and sustainable solutions for biotech and pharma

    Düsseldorf, Germany, October 21, 2021. Gerresheimer's global presence in Europe, America and Asia at numerous certified own production sites enables regional and market-oriented cooperation and logistics with partners in the pharma world. At CPHI Worldwide in Milano the company will be presenting its innovative, solution-oriented and sustainable developments. The wide range of products includes solutions, products and delivery systems for drugs, vaccines or high potency biologics.
  • Whitepaper Biological Solutions

    Dedicated primary packaging for biological active ingredients : from reduced silicone- , and polymer syringes over ready-to-fill glass- and COP vials to customized product developments  and much more.


  • Video Services Beyond Product

    Next to the primary packaging container itself services and data are needed, to proof usability and allow registration. Chemical, functionality, physical and regulatory aspects have to be covered in the complete value chain. Support on registration, lifecycle management, continuous improvement and more are offered by Gerresheimer. Let’s go through the capabilities of an experienced supplierThis webinar originally aired as part of Pharmapack Europe 2021
  • Webinar On the Road to Decarbonisation - Gerresheimer Moulded Glass

    The presentation will be about the Gerresheimer – roadmap to decarbonization. The speaker will cover supplier-specific approaches like the furnace technology. Furthermore, Value-chain-comprising approaches in Ph-business (eg eco-design development) will be explained. In the end, success stories about joint value-chain comprising decarbonisation will be told. This session was broadcast as part of the Pharmapack show.
  • Webinar Technology & Device Trends Driving Care from Hospital to Home

    Smart devices which enable remote monitoring and self-administration have been on the market for a few years, but pandemic has fast-tracked growth in this sector. At a time when visiting a hospital to receive care was potentially dangerous for more vulnerable patients, and health centres were overwhelmed and lacked capacity, focus shifted to devices and solutions which would enable safe administration of medications in the home setting. This webinar will examine the future of ‘patient-centric’ telemedicine solutions – from the most innovative devices entering the market, to the role of logistics companies in creating a new infrastructure around remote care. By attending this webinar, you will understand more about: The impact of COVID on ‘home health’ and remote monitoring Device innovation – what are the latest products entering the market Maintaining adherence at home Supporting the logistical requirements of home healthcare